49% buyers of institutions opening or closing positions this quarter
10 more exits than new buyers, ownership rose 112.78 percentage points vs the prior quarter, and no widely-followed fund managers in the top 25.
49% buyers of institutions opening or closing positions this quarter
195.1% institutional ownership
Capital Research Global portfolio allocation
Institutional ownership vs Drug Manufacturers - General peers
No Form 4 insider transactions on file
Latest positioning in ABBV across 13F flow, ownership shift, marquee holders, and holder-count growth.
Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ABBV held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Employees Provident Fund Board | 8.6M | $460.04B | — | 0.487% | 0.71% |
| 2 | BlackRock, Inc. | 150.7M | $32.79B | -0.3% | 8.523% | 0.57% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 114.9M | $24.99B | — | 6.495% | 0.63% |
| 4 | STATE STREET CORP | 81.2M | $17.66B | +0.3% | 4.592% | 0.61% |
| 5 | Kentucky Farm Bureau Mutual Insurance Co | 332K | $12.26B | — | 0.019% | 0.28% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 49.5M | $10.77B | — | 2.800% | 0.57% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 46.7M | $10.14B | +4.7% | 2.642% | 0.63% |
| 8 | MORGAN STANLEY | 38.0M | $8.27B | -5.1% | 2.149% | 0.50% |
| 9 | Capital Research Global Investors | 31.3M | $6.80B | +23.0% | 1.767% | 1.05% |
| 10 | BANK OF AMERICA CORP /DE/ | 23.9M | $5.21B | -7.3% | 1.353% | 0.38% |
| 11 | FMR LLC | 21.8M | $4.73B | -3.7% | 1.230% | 0.25% |
| 12 | NORTHERN TRUST CORP | 21.2M | $4.61B | -2.4% | 1.199% | 0.61% |
| 13 | American State Bank (Iowa) | 96K | $4.19B | — | 0.005% | 0.41% |
| 14 | GOLDMAN SACHS GROUP INC | 16.4M | $3.58B | +19.5% | 0.929% | 0.41% |
| 15 | Capital World Investors | 15.8M | $3.45B | +21.2% | 0.896% | 0.47% |
| 16 | UBS Group AG | 15.1M | $3.29B | +25.4% | 0.856% | 0.49% |
| 17 | FRANKLIN RESOURCES INC | 14.6M | $3.16B | -2.2% | 0.823% | 0.78% |
| 18 | Capital International Investors | 14.4M | $3.13B | +23.3% | 0.815% | 0.73% |
| 19 | UBS ASSET MANAGEMENT AMERICAS INC | 14.2M | $3.08B | +9.6% | 0.801% | 0.64% |
| 20 | Bank of New York Mellon Corp | 13.3M | $2.89B | -1.6% | 0.751% | 0.53% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13.0M | $2.82B | -48.5% | 0.733% | 0.43% |
| 22 | Legal & General Group Plc | 12.2M | $2.64B | +0.2% | 0.688% | 0.61% |
| 23 | Nuveen, LLC | 11.1M | $2.42B | +29.1% | 0.628% | 0.65% |
| 24 | AMERIPRISE FINANCIAL INC | 11.1M | $2.41B | +10.0% | 0.626% | 0.56% |
| 25 | Amundi | 10.7M | $2.33B | +2.4% | 0.605% | 0.63% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ABBV — a direct measure of their conviction.
Filings activity in ABBV during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ABBV position in Q1 2026
Institutions that fully closed their ABBV position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 3,959 | 0.3% | 195.14% | +112.78 pp | $735.49B | +137% |
| Q4 2025 | 3,969 | +5.8% | 82.36% | 7.59 pp | $310.40B | 8.4% |
| Q3 2025 | 3,752 | +3.6% | 89.95% | 11.80 pp | $339.03B | 12% |
| Q2 2025 | 3,623 | 0.4% | 101.75% | +30.82 pp | $383.48B | +43% |
| Q1 2025 | 3,637 | +3.6% | 70.93% | +7.83 pp | $267.32B | +12% |
| Q4 2024 | 3,509 | +5.7% | 63.10% | 32.62 pp | $237.84B | 34% |
| Q3 2024 | 3,321 | +4.2% | 95.72% | 59.77 pp | $360.77B | 38% |
| Q2 2024 | 3,187 | — | 155.49% | — | $586.06B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
No recent Form 4 insider transactions on file for ABBV.
Quick answers to the most common questions about buying ABBV stock.
Based on Q1 2026 13F filings, institutional ownership of AbbVie Inc. stands at 195.1%, held across 3,959 reporting institutions.
Employees Provident Fund Board is the largest reported institutional holder of ABBV, with approximately 8,610,547 shares worth $460.04B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ABBV.
Our composite Smart Money Score for ABBV is 45 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
281 institutions opened new positions in ABBV during Q1 2026, while 291 fully exited. 732 added to existing positions and 2,935 trimmed.
ABBV institutional ownership rose by 112.78 percentage points quarter-over-quarter, with a net change of — holders.
The top 10 institutions account for 80.1% of all reported 13F value in ABBV, and the top 25 account for 86.7%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.